Stonepine Capital Management as of March 31, 2020
Portfolio Holdings for Stonepine Capital Management
Stonepine Capital Management holds 27 positions in its portfolio as reported in the March 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ligand Pharmaceuticals In (LGND) | 12.4 | $12M | 161k | 72.72 | |
| Iveric Bio | 9.4 | $8.9M | 2.6M | 3.44 | |
| Cti Biopharma | 6.3 | $5.9M | 6.4M | 0.92 | |
| Amarin Corporation | 5.6 | $5.3M | 1.3M | 4.00 | |
| Affimed Therapeutics B V | 5.0 | $4.7M | 3.0M | 1.58 | |
| Catalyst Biosciences | 4.7 | $4.5M | 1.0M | 4.37 | |
| D Stemline Therapeutics | 4.5 | $4.3M | 887k | 4.84 | |
| Xoma Corp Del (XOMA) | 4.5 | $4.2M | 209k | 20.35 | |
| Opiant Pharmaceuticals | 3.9 | $3.6M | 381k | 9.58 | |
| Neos Therapeutics | 3.7 | $3.5M | 4.7M | 0.75 | |
| Oxford Immunotec Global | 3.7 | $3.5M | 374k | 9.26 | |
| Evolus (EOLS) | 3.6 | $3.4M | 823k | 4.15 | |
| Adamas Pharmaceuticals | 3.6 | $3.4M | 1.2M | 2.89 | |
| Cumberland Pharmaceuticals (CPIX) | 3.5 | $3.3M | 908k | 3.63 | |
| Apollo Endosurgery | 3.4 | $3.2M | 1.7M | 1.92 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 3.4 | $3.2M | 1.3M | 2.48 | |
| Aegerion Pharmaceuticals Inc note 5.000% 4/0 | 3.1 | $2.9M | 3.0M | 0.95 | |
| BioDelivery Sciences International | 3.0 | $2.9M | 755k | 3.79 | |
| Chiasma | 2.9 | $2.7M | 744k | 3.65 | |
| Diamedica Therapeutics (DMAC) | 2.4 | $2.3M | 825k | 2.80 | |
| Seaspine Holdings | 2.2 | $2.1M | 253k | 8.17 | |
| Applied Genetic Technol Corp C | 2.0 | $1.9M | 587k | 3.28 | |
| Baudax Bio | 1.6 | $1.5M | 610k | 2.48 | |
| Interpace Biosciences (IDXG) | 1.0 | $924k | 178k | 5.18 | |
| Antares Pharma | 0.4 | $357k | 151k | 2.36 | |
| Htg Molecular Diagnostics | 0.3 | $323k | 993k | 0.33 | |
| Rigel Pharmaceuticals | 0.0 | $16k | 10k | 1.60 |
